Literature DB >> 16242192

Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases.

Matthias John1, Andre Lange, Soeren Hoernig, Christian Witt, Stefan D Anker.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a multisystemic inflammatory disease characterized by pulmonary and extrapulmonary symptoms. The impaired lung function has long-term implications on metabolism and homeostasis of many organ systems such as the skeleton, heart, brain and skeletal muscle. The occurrence and prevalence of anemia in COPD has rarely been studied. Anemia is such a common and simple clinical finding that we may underestimate its physiological relevance in COPD. The aim of the study was to retrospectively investigate the prevalence of anemia in a large population of COPD patients and to compare it to patients with chronic heart failure, renal insufficiency, cancer and asthma. A population of 7337 patients that was treated in the University Hospital Charité, Berlin, Germany, from 1996 to 2003 was subsetted according to the ICD-9/10 code of the discharge diagnoses into the above-mentioned diagnoses groups. The overall prevalence of anemia in COPD patients was 23.1%. It was comparable to the prevalence of anemia we found in patients with chronic heart failure (23.3%). Patients with renal insufficiency and cancer presented the highest anemia frequencies. The high prevalence of anemia in hospitalised COPD patients that were treated mostly for exacerbations gives evidence that anemia is also a comorbidity in COPD and may contribute to exercise limitation and dyspnoea.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16242192     DOI: 10.1016/j.ijcard.2005.07.043

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  23 in total

1.  The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure.

Authors:  Mitja Lainscak; Lea Majc Hodoscek; Hans-Dirk Düngen; Mathias Rauchhaus; Wolfram Doehner; Stefan D Anker; Stephan von Haehling
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 2.  Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.

Authors:  Claire Healy; Natalia Munoz-Wolf; Janné Strydom; Lynne Faherty; Niamh C Williams; Sarah Kenny; Seamas C Donnelly; Suzanne M Cloonan
Journal:  Respir Res       Date:  2021-04-29

Review 3.  Comorbidities in chronic obstructive pulmonary disease.

Authors:  Wissam M Chatila; Byron M Thomashow; Omar A Minai; Gerard J Criner; Barry J Make
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

4.  Chronic obstructive pulmonary disease, hospital visits, and comorbidities: National Survey of Residential Care Facilities, 2010.

Authors:  Anne G Wheaton; Earl S Ford; Timothy J Cunningham; Janet B Croft
Journal:  J Aging Health       Date:  2014-10-05

Review 5.  New modalities of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease.

Authors:  Martijn A Spruit; Emiel F M Wouters
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

Review 6.  Contribution of the environment and comorbidities to chronic obstructive pulmonary disease phenotypes.

Authors:  Carlos H Martinez; MeiLan K Han
Journal:  Med Clin North Am       Date:  2012-03-22       Impact factor: 5.456

7.  The "Iron"-y of Iron Overload and Iron Deficiency in Chronic Obstructive Pulmonary Disease.

Authors:  Suzanne M Cloonan; Sharon Mumby; Ian M Adcock; Augustine M K Choi; Kian Fan Chung; Gregory J Quinlan
Journal:  Am J Respir Crit Care Med       Date:  2017-11-01       Impact factor: 21.405

8.  Clinical factors affecting the direct cost of patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Tacettin Ornek; Meltem Tor; Remzi Altın; Figen Atalay; Elif Geredeli; Omer Soylu; Fatma Erboy
Journal:  Int J Med Sci       Date:  2012-06-05       Impact factor: 3.738

9.  Changes in blood hemoglobin and blood gases PaO2 and PaCO2 in severe COPD overa three-year telemonitored program of long-term oxygen treatment.

Authors:  Roberto W Dal Negro; Silvia Tognella; Luca Bonadiman; Paola Turco
Journal:  Multidiscip Respir Med       Date:  2012-07-17

10.  Venous admixture in COPD: pathophysiology and therapeutic approaches.

Authors:  Christopher B Cooper; Bartolome Celli
Journal:  COPD       Date:  2008-12       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.